161715-27-1 Usage
Description
3-Hydroxy-1-(1,3-thiazolin-2-yl)azetidine is a chemical compound characterized by its molecular formula C6H10N2OS. It is a thiazoline derivative featuring a hydroxy group and an azetidine ring, which contributes to its unique structure and potential biological activity. 3-Hydroxy-1-(1,3-thiazolin-2-yl)azetidine holds promise in pharmaceutical and medicinal chemistry due to its potential anti-tumor, anti-inflammatory, and antimicrobial properties, with the hydroxy group possibly enhancing its pharmacological profile.
Uses
Used in Pharmaceutical Industry:
3-Hydroxy-1-(1,3-thiazolin-2-yl)azetidine is used as a potential therapeutic agent for various medical conditions due to its potential anti-tumor, anti-inflammatory, and antimicrobial activities. Its unique structure and the presence of a hydroxy group may contribute to its enhanced pharmacological properties, making it a candidate for drug discovery and development.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 3-Hydroxy-1-(1,3-thiazolin-2-yl)azetidine serves as a subject of study for its potential to be modified and optimized for specific therapeutic applications. Its thiazoline core and hydroxyl functionality offer opportunities for the design of new drugs with improved efficacy and selectivity.
Further research is necessary to fully explore the potential applications and therapeutic benefits of 3-Hydroxy-1-(1,3-thiazolin-2-yl)azetidine across different medical and scientific domains.
Check Digit Verification of cas no
The CAS Registry Mumber 161715-27-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,7,1 and 5 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 161715-27:
(8*1)+(7*6)+(6*1)+(5*7)+(4*1)+(3*5)+(2*2)+(1*7)=121
121 % 10 = 1
So 161715-27-1 is a valid CAS Registry Number.
161715-27-1Relevant articles and documents
Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084
Isoda, Takeshi,Ushirogochi, Hideki,Satoh, Koichi,Takasaki, Tsuyoshi,Yamamura, Itsuki,Sato, Chisato,Mihira, Ado,Abe, Takao,Tamai, Satoshi,Yamamoto, Shigeki,Kumagai, Toshio,Nagao, Yoshimitsu
, p. 241 - 247 (2007/10/03)
We discovered an orally active carbapenem, L-084, through pharmacokinetic studies on various prodrug esters of (1R,5S,6S)-6-[(R)-1-hydroxyethyl]-1-methyl- 2-[1-(1,3-thiazolin-2-yl)azetidin-3-yl]thio-1-carbapen-2-em-3-carboxylic acid (LJC11,036). L-084 showed a strong antimicrobial activity against Gram-positive and Gram-negative bacteria and exhibited the highest intestinal absorption among synthesized prodrugs of LJC11,036. Japan Antibiotics Research Association.
